We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $494K invested in Sage Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 185 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77.93% less ownership

Funds ownership: 78.02% → 0.09% (-78%)

97% less funds holding

Funds holding: 191 → 5 (-186)

100% less capital invested

Capital invested by funds: $446M → $494K (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 185

Holders
5
Holders Change
-186
Holders Change %
-97.38%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
185
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$150K
2
IA
IFP Advisors
Florida
+$45

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$55.4M
2
BlackRock
BlackRock
New York
-$41.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$29.8M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$17.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
126
US Bancorp
Minnesota
– -$125K -13,717 Closed
Lazard Asset Management
127
Lazard Asset Management
New York
– -$120K -13,232 Closed
Stifel Financial
128
Stifel Financial
Missouri
– -$118K -12,955 Closed
MFG
129
Merit Financial Group
Georgia
– -$117K -12,876 Closed
CUAMC
130
China Universal Asset Management Company
China
– -$115K -12,577 Closed
PCM
131
Prelude Capital Management
New York
– -$112K -12,229 Closed
QCM
132
Quantinno Capital Management
New York
– -$110K -12,052 Closed
New York State Common Retirement Fund
133
New York State Common Retirement Fund
New York
– -$110K -12,046 Closed
TSS
134
Two Sigma Securities
New York
– -$107K -11,714 Closed
GS
135
GTS Securities
New York
– -$99.6K -10,921 Closed
EGM
136
Engineers Gate Manager
New York
– -$99.1K -10,868 Closed
CGL
137
Clarius Group LLC
Washington
– -$91.2K -10,000 Closed
Public Employees Retirement Association of Colorado
138
Public Employees Retirement Association of Colorado
Colorado
– -$82K -8,938 Closed
PCM
139
PenderFund Capital Management
British Columbia, Canada
– -$75.7K -8,300 Closed
TRCT
140
Tower Research Capital (TRC)
New York
– -$65.5K -7,185 Closed
BNP Paribas Financial Markets
141
BNP Paribas Financial Markets
France
– -$55.3K -6,061 Closed
EP
142
Essential Partners
California
– -$54K -5,924 Closed
Royal Bank of Canada
143
Royal Bank of Canada
Ontario, Canada
– -$53K -5,879 Closed
AIP
144
Ameritas Investment Partners
Nebraska
– -$47.9K -5,253 Closed
Legal & General Group
145
Legal & General Group
United Kingdom
– -$47.2K -5,175 Closed
Fidelity Investments
146
Fidelity Investments
Massachusetts
– -$37.7K -4,133 Closed
California State Teachers Retirement System (CalSTRS)
147
California State Teachers Retirement System (CalSTRS)
California
– -$36.8K -4,034 Closed
EWA
148
EverSource Wealth Advisors
Alabama
– -$25.4K -2,782 Closed
Mirae Asset Global Investments
149
Mirae Asset Global Investments
South Korea
– -$22.1K -2,419 Closed
CA
150
Clearstead Advisors
Ohio
– -$17.5K -1,924 Closed
4 5
6
7 8

SAGE Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2025, worth a combined $494K — down 100% from $446M a quarter earlier.

Sellers outnumbered buyers: 185 funds closed out of SAGE and 0 opened new positions — a net loss of 185 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $150K. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $55.4M sold.

  • 5 institutional investors held Sage Therapeutics (SAGE) as of Q3 2025, down from 191 in Q2 2025.
  • Funds reported $494K of Sage Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q3 2025 and 185 closed out, a net change of -185 holders.
  • The largest Sage Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $150K added.
  • The largest Sage Therapeutics seller in Q3 2025 was Madison Avenue Partners, an estimated $55.4M sold.

Based on aggregated 13F filings for Q3 2025.